Moderna (MRNA) PT Raised to $38 at BofA Securities
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $63.65 --0%
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 7
Rating Summary:
5 Buy, 21 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 7
Join SI Premium – FREE
BofA Securities analyst Alec Stranahan raised the price target on Moderna (NASDAQ: MRNA) to $38.00 (from $34.00) while maintaining a Underperform rating.
You May Also Be Interested In
- Blaize Inc. (BZAI) PT Lowered to $2 at Rosenblatt
- Target (TGT) PT Raised to $147 at Truist Securities
- Nuscale Power (SMR) PT Lowered to $15 at B.Riley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
